Human MIP-3 alpha ELISA Kit (CCL20)
- Recombinant
- SimpleStep
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Human MIP-3 alpha ELISA Kit (CCL20) is a single-wash 90-min Simplestep used to quantify Human MIP-3 alpha (CCL20) with a sensitivity of 5.11 pg/ml. The assay uses a simple mix-wash-read protocol with just one incubation and one wash step.
- Colorimetric Sandwich ELISA - 450 nm readout : works on any standard plate reader
- Design your own immunoassay: we also offer the conjugation-ready antibody pair
View Alternative Names
LARC, MIP3A, SCYA20, CCL20, C-C motif chemokine 20, Beta-chemokine exodus-1, CC chemokine LARC, Liver and activation-regulated chemokine, Macrophage inflammatory protein 3 alpha, Small-inducible cytokine A20, MIP-3-alpha
- ELISA
Supplier Data
ELISA - Human MIP-3 alpha ELISA Kit (CCL20) (AB269562)
- sELISA
Supplier Data
Sandwich ELISA - Human MIP-3 alpha ELISA Kit (CCL20) (AB269562)
Interpolated concentrations of native MIP-3 alpha in human cell culture supernatant samples.
The concentrations of MIP-3 alpha were measured in duplicates, interpolated from the MIP-3 alpha standard curves and corrected for sample dilution. Undiluted samples are as follows : unstimulated PBMC 100%, 1.5% PHA stimulated PBMC cell culture supernatant 50%, unstimulated THP-1 100%, and 1ug/mL IFN-gamma and 1ug/mL LPS stimulated THP-1 cell culture supernatant 50%. The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean MIP-3 alpha concentration was determined to be undetectable in unstimulated PBMC supernatant, 1614.14 pg/mL in PHA stimulated PBMC, undetectable in unstimulated THP-1 supernatant, and 1209.37 pg/mL in IFN-gamma and LPS stimulated THP-1 supernatant.
- sELISA
Supplier Data
Sandwich ELISA - Human MIP-3 alpha ELISA Kit (CCL20) (AB269562)
Human MIP-3 standard curve comparison.
Standard Curve comparison between the original human MMP3 SimpleStep ELISA kit (ab178015) and current human MMP3 SimpleStep ELISA kit (ab269562).
- sELISA
Supplier Data
Sandwich ELISA - Human MIP-3 alpha ELISA Kit (CCL20) (AB269562)
Example of human MIP-3 alpha standard curve in Sample Diluent NS.
The MIP-3 alpha standard curve was prepared as described in Section 10. Raw data values are shown in the table. Background-subtracted data values (mean +/- SD) are graphed.
Reactivity data
Product details
Human MIP-3 alpha ELISA Kit (CCL20) ab269562 is a rapid single-wash 90-min Sandwich ELISA to measure Human MIP-3 alpha (CCL20)in cell culture supernatant, EDTA plasma, heparin plasma, serum. This SimpleStep sensitivity is 5.11 pg/mL.
How the assay works
Human MIP-3 alpha (CCL20)SimpleStep ELISA®employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our SimpleStep ELISA® plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. See the SimpleStep ELISA® protocol summary in the image section for further details.
Assay Specificity
Our SimpleStep ELISA® kits use recombinant monoclonal antibodies rigorously validated to ensure the highest level of consistency and reproducibility, improved sensitivity and specificity and ease of scalability and security of supply.
Please refer to our protocol booklet for more details.
Human MIP-3 alpha ELISA Kit (CCL20) ab269562 protocol summary
1. Mix: add samples/standards to the wells together with the capture and detector antibody cocktail. Incubate 1 hr at room temperature
2. Wash
3. Add TMB development solution - incubate for 10 min
4. Add Stop solution
5. Read the results on a plate reader at 450 nm
MIP-3 alpha (MIP3a, CCL20) is a CC chemokine with a selective chemotactic activity for lymphocytes and dendritic cells. Its main function is to inhibit proliferation of myeloid progenitors in colony formation assays. MIP-3 alpha may be involved in formation and function of the mucosal lymphoid tissues by attracting lymphocytes and dendritic cells towards epithelial cells. C-terminal processed forms have been shown to be equally chemotactically active for leukocytes. MIP-3 alpha is expressed predominantly in the liver, lymph nodes, appendix, peripheral blood lymphocytes, and fetal lung. There are also low levels in thymus, prostate, testis, small intestine and colon. MIP-3 alpha is induced by bacterial lipopolysaccharides, TNF and IFNG/IFN-gamma. Stimulation with phorbol myristate acetate (PMA) in U-937 cell line and Bowes melanoma will induce expression. MIP-3 alpha shares 64.2%, 60.8%, 69.8%, 86.5% sequence homology with mouse, rat, cow, and monkey, respectively.
Precision
Recovery
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MIP-3 alpha contributes to the immune system by recruiting immune cells to sites of inflammation or injury. It is not part of a larger protein complex. Its main function is binding to the CCR6 receptor on target cells. This interaction mediates the migration and activation of the immune cells critical for initiating the immune response by increasing cell surface adhesion and motility. By drawing immune cells MIP-3 alpha significantly influences the body's capacity to fight infections and regulate inflammatory processes.
Pathways
MIP-3 alpha is integral to the inflammatory response and chemokine signaling pathways. It is involved in the immune system's adaptive response through its interaction with CCR6. This pathway overlaps with other chemokines such as MIP-1 and MIP-2 which also aid in immune cell recruitment. Furthermore MIP-3 alpha’s engagement in these pathways facilitates intercellular communication during immune responses pivotal for maintaining homeostasis and immune surveillance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in immunology 14:1216376 PubMed37398643
2023
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 23:e55871 PubMed36200589
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 20:248 PubMed35642002
2022
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 23:e54271 PubMed35403791
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com